RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS
DRGS was delisted on the 6th of July, 2015.
4 hedge funds and large institutions have $263K invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
0% more funds holding
Funds holding: 4 → 4 (0)
43% less capital invested
Capital invested by funds: $463K → $263K (-$200K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$232K |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$52 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$374K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $239K | +$232K | +4,476 | New |
|
2
UBS Group
Zurich,
Switzerland
| $13K | +$13K | +250 | New |
|
|
AIG
3
American International Group
New York
| $10.7K | – | – | – |
|
|
4
Goldman Sachs
New York
| – | -$374K | -7,350 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$5K | -104 | Closed |
|
|
6
Parallax Volatility Advisers
San Francisco,
California
| – | +$52 | +1 | New |
|
DRGS Hedge Fund Activity: Q4 2014 in Review
4 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q4 2014, worth a combined $263K — down 43% from $463K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new DRGS positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $232K. The largest seller was Goldman Sachs, exiting entirely with an estimated $374K sold.
- 4 institutional investors held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q4 2014, unchanged from Q3 2014.
- Funds reported $263K of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q4 2014, down 43% quarter-over-quarter.
- 3 funds opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q4 2014 and 2 closed out, a net change of +1 holder.
- The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS buyer in Q4 2014 was Jane Street, an estimated $232K added.
- The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q4 2014 was Goldman Sachs, an estimated $374K sold.
Based on aggregated 13F filings for Q4 2014.